Home › COVID-19 and Coronavirus Infections › Illinois › Chicago
COVID-19 and Coronavirus Infections clinical trials in Chicago, IL
3 studies for COVID-19 and Coronavirus Infections are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
RecruitingPhase 3
- Northwestern Memorial Hospital, Chicago
- Northwestern University Feinberg School of Medicine, Chicago
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
RecruitingPhase 3
- Illinois Research Network (ILLInet), University of Illinois Chicago, Chicago
Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
RecruitingPhase 3
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
COVID-19 and Coronavirus Infections trials in other cities
- Washington, DC7 studies
- Boston, MA5 studies
- Durham, NC5 studies
- Dallas, TX5 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
- Los Angeles, CA4 studies
- New York City, NY4 studies
- Hialeah, FL4 studies
- San Francisco, CA3 studies
- Seattle, WA3 studies
- Cincinnati, OH3 studies
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer59 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Lung Cancer41 studies
- Obesity41 studies
- Ovarian Cancer36 studies
- Colorectal Cancer34 studies
- Stroke34 studies
- Heart Failure31 studies
- Overweight29 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.